Study of Different Local Treatments of Post COVID-19 Smell Dysfunction

Overview

Journal Iran J Otorhinolaryngol

Publisher Mashhad University of Medical Sciences

Specialty Otorhinolaryngology

Date 2022 Dec 7

PMID 36474485

Authors

Soad A Mohamad

Ahmed M Badawi

Ramy M El-Sabaa

Hosam M Ahmad

Asmaa S Mohamed

Affiliations

Soon will be listed here.

Abstract

Introduction: This study was designed to differentiate between the impact of the topical nasal spray of corticosteroids, antihistamines, a combination of them, and normal 0.2% saline in treating patients with post-coronavirus disease 2019 (COVID-19) smell dysfunction.

Materials And Methods: Patients with hyposmia or anosmia (n = 240), who recently recovered from COVID-19, were enrolled in this trial and were randomly assigned to four parallel groups. Group I (G1) received a combination of topical corticosteroid and antihistamine nasal spray (n = 60). Group II (G2) received topical corticosteroid nasal spray (n = 60). Group III (G3) received antihistamine nasal spray (n = 60). Group IV (G4) received 0.2% normal nasal saline nasal spray (n = 60). The treatments were used in all groups for 3 weeks. The sense of smell was assessed using the butanol threshold and discrimination tests. The smell tests were evaluated weekly for 3 weeks.

Results: The mean age of the patients was 51.9 ± 7.1 years; moreover, 83.8% and 16.2% were male and female, respectively. The results of the smell tests in the first week significantly improved with those in the third week (P< 0.001). The greatest degree of improvement was found in the first group, followed by the second, third, and fourth groups.

Conclusions: The results suggest the ability of combination therapy of corticosteroid and antihistamine nasal spray to manage post-COVID-19 hyposmia or anosmia; however, this combination therapy was not superior to corticosteroid nasal spray. Trial registration ID: UMIN000043537.

References

Small P, Keith P, Kim H . Allergic rhinitis. Allergy Asthma Clin Immunol. 2018; 14(Suppl 2):51. PMC: 6156899. DOI: 10.1186/s13223-018-0280-7. View

Abdelalim A, Mohamady A, Elsayed R, Elawady M, Ghallab A . Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial. Am J Otolaryngol. 2021; 42(2):102884. PMC: 7836546. DOI: 10.1016/j.amjoto.2020.102884. View

El Naggar M, Kale S, Aldren C, Martin F . Effect of Beconase nasal spray on olfactory function in post-nasal polypectomy patients: a prospective controlled trial. J Laryngol Otol. 1995; 109(10):941-4. DOI: 10.1017/s002221510013172x. View

Sivam A, Jeswani S, Reder L, Wang J, deTineo M, Taxy J . Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010; 24(4):286-90. DOI: 10.2500/ajra.2010.24.3478. View

Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View

Whitcroft K, Hummel T . Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020; 323(24):2512-2514. DOI: 10.1001/jama.2020.8391. View

Huang H, Cai S, Li Y, Li Y, Fan Y, Li L . Prognostic Factors for COVID-19 Pneumonia Progression to Severe Symptoms Based on Earlier Clinical Features: A Retrospective Analysis. Front Med (Lausanne). 2020; 7:557453. PMC: 7571455. DOI: 10.3389/fmed.2020.557453. View

Mott A, Cain W, Lafreniere D, Leonard G, Gent J, Frank M . Topical corticosteroid treatment of anosmia associated with nasal and sinus disease. Arch Otolaryngol Head Neck Surg. 1997; 123(4):367-72. DOI: 10.1001/archotol.1997.01900040009001. View

Kalpaklioglu A, Kavut A . Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis. Am J Rhinol Allergy. 2010; 24(1):29-33. DOI: 10.2500/ajra.2010.24.3423. View

10.

Afrin L, Weinstock L, Molderings G . Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020; 100:327-332. PMC: 7529115. DOI: 10.1016/j.ijid.2020.09.016. View

11.

Moran Blanco J, Alvarenga Bonilla J, Homma S, Suzuki K, Fremont-Smith P, Villar Gomez de Las Heras K . Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients. Pulm Pharmacol Ther. 2021; 67:101989. PMC: 7833340. DOI: 10.1016/j.pupt.2021.101989. View

12.

Islek A, Balci M . Diagnostic Value of Butanol Threshold Test in COVID-19 Related Olfactory Dysfunction. Indian J Otolaryngol Head Neck Surg. 2021; 74(Suppl 2):2873-2877. PMC: 7865114. DOI: 10.1007/s12070-021-02420-3. View

13.

Tanasa I, Manciuc C, Carauleanu A, Navolan D, Bohiltea R, Nemescu D . Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?. Exp Ther Med. 2020; 20(3):2344-2347. PMC: 7401831. DOI: 10.3892/etm.2020.8808. View

14.

Catana I, Chirila M, Negoias S, Bologa R, Cosgarea M . Effects of corticosteroids on hyposmia in persistent allergic rhinitis. Clujul Med. 2015; 86(2):117-20. PMC: 4462432. View

15.

Han A, Mukdad L, Long J, Lopez I . Anosmia in COVID-19: Mechanisms and Significance. Chem Senses. 2020; . PMC: 7449368. DOI: 10.1093/chemse/bjaa040. View

16.

Guilemany J, Garcia-Pinero A, Alobid I, Cardelus S, Centellas S, Bartra J . Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope. 2009; 119(2):233-8. DOI: 10.1002/lary.20075. View

17.

Russell B, Moss C, Rigg A, Van Hemelrijck M . COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?. Ecancermedicalscience. 2020; 14:1023. PMC: 7105332. DOI: 10.3332/ecancer.2020.1023. View

18.

Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S . Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2020; 27(2):258-263. PMC: 7534895. DOI: 10.1016/j.cmi.2020.09.052. View

19.

Cataldi M, Maurer M, Taglialatela M, Church M . Cardiac safety of second-generation H -antihistamines when updosed in chronic spontaneous urticaria. Clin Exp Allergy. 2019; 49(12):1615-1623. DOI: 10.1111/cea.13500. View

20.

Baradaranfar M, Ahmadi Z, Dadgarnia M, Bemanian M, Atighechi S, Karimi G . Comparison of the effect of endoscopic sinus surgery versus medical therapy on olfaction in nasal polyposis. Eur Arch Otorhinolaryngol. 2013; 271(2):311-6. DOI: 10.1007/s00405-013-2553-6. View